2016 American Transplant Congress Archives - Page 3 of 180

5:30pm-7:30pm: Alloantibody Suppression by Bruton Tyrosine Kinase Antagonist Ibrutinib Is Associated with a Moderate Splenic B-Cell Reduction.

N.-N. Chai, I. Kim, S. Jordan, A. Klein, G. Wu.

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression • Halls C&D

5:30pm-7:30pm: An Analysis of Factors Associated with Pancreas Allograft Thrombosis.

J. Steggerda, K. Bornhurst, A. Annamalai, A. Peng, J. Mirocha, D. Dafoe.

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics • Halls C&D

5:30pm-7:30pm: Analysis of T Cell Receptor Repertoire in Routine Renal Allograft Biopsy.

R. Reindl-Schwaighofer,¹ J. Weinberger,¹ R. Jimenez-Heredia,¹ J. Sunzenauer,¹ S. Schaller,² S. Winkler,² R. Oberbauer.¹

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D

5:30pm-7:30pm: Appraisal of Alternative Immunosuppression Regimens in Intestinal Transplant Recipients: A Single Center Experience.

R. Patel, M. Keck, D. Collier, M. Vacha.

Poster Session A: Small Bowel: All Topics • Halls C&D

5:30pm-7:30pm: Arteriolar Hyalinosis on Renal Transplant Protocol Biopsies Is Not Associated with Tacrolimus Exposure.

S. Yilmaz,¹ D. Shaffer,² Y. Qazi,³ F. Shihab,⁴ K. McCague,⁵ D. Patel,⁵ F. Vincenti.⁶

Poster Session A: Long Term Outcomes in Kidney Transplantation • Halls C&D

5:30pm-7:30pm: ASC-Deficient Dendritic Cells Exhibit Activation Defects and a Reduced Ability to Stimulate Allogeneic T Cells.

A. Scheinok, A. Shigeoka, S. Kasimsetty, R. Elahimehr, D. McKay.

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression • Halls C&D

5:30pm-7:30pm: Assessing the Induction of Tolerance to Vascularized Composite Allotransplantation in Miniature Swine.

J. Walch, J. Alonso-Escalante, H. Wang, B. Oh, M. Iglesias, A. Lee, G. Brandacher, G. Raimondi.

Poster Session A: Clinical Vascularized Composite Allotransplantation • Halls C&D

5:30pm-7:30pm: Assessing the Role of Everolimus in Reducing Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation for Patients within UCSF Criteria: Re-Inventing the Role of Mammalian Target of Rapamycine Inhibitors.

L.-B. Jeng, A. Thorat, H.-R. Yang, T.-H. Chen, S.-C. Hsu.

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Halls C&D

5:30pm-7:30pm: Association Between GFR Decline and Long Term Outcome in Renal Transplantation.

A. Delay,¹ O. Moranne,² N. Maillard,¹ E. Alamartine,¹ C. Mariat.¹

Poster Session A: Poster Session III: Kidney Complications-Other • Halls C&D

5:30pm-7:30pm: Association Between Pretransplant Body Mass Index and Outcomes in Patients Undergoing Living Kidney Transplantation: A Consideration of Gender Differences.

M. Okumi,¹ K. Unagami,¹ M. Furusawa,¹ T. Hirai,¹ Y. Okabe,² K. Masutani,³ T. Shimizu,¹ K. Omoto,⁴ H. Ishida,¹ T. Kitazono,³ K. Tanabe,¹ The Japan Academic Consortium of Kidney Transplantation (JACK).

Poster Session A: Poster Session III: Kidney Complications-Other • Halls C&D